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Delayed graft function (DGF) is a common complication in renal transplant recipients 
receiving kidneys from brain-dead donors. Brain death (BD)-related lipid peroxidation, 
measured as maldondialdehyde (MDA) levels, correlate with DGF in renal transplant 
recipients. We aimed to assess the effects of MnTMPyP treatment of brain-dead rats on 
renal function in an ex vivo isolated perfused kidney (IPK) model. 
Methods 
BD induction was performed in 18 mechanically ventilated male Fisher rats by inflating 
a 4.0F Fogarty catheter in the epidural space. Rats were observed for 4 hrs following BD 
induction. Rats were maintained hemodynamically stable through the administration of 
colloids and norepinephrine. After 4 hrs, the left kidney was cannulated and reperfused in 
the IPK model for 90 min. The other organs, urine and blood were collected. Perfusate and 
urine samples were collected at different time points in the IPK model. 
Results 
BD resulted in increased levels of renal superoxide and MDA levels which were attenuated 
by MnTMPyP treatment. In the IPK model, MnTMPyP treatment resulted in increased renal 
blood flow, decreased perfusate creatinine levels, increased sodium absorption, increased 
urine output, and decreased edema. 
Conclusion 
MnTMPyP treatment in brain-dead rats leads to improved renal function ex vivo. MnTMPyP 
treatment could lead to improved transplantation outcomes.
INTRODUCTION
Delayed graft function (DGF) is a complication occurring in 20-35% of renal transplant 
recipients1-3. DGF is associated with acute rejection, chronic allograft failure, and 
decreased renal function3-6. Kidney grafts retrieved from brain-dead donors, the most 
frequently transplanted grafts, show DGF rates of 15-30%7,8. These findings cannot be 
solely explained by human leukocyte antigen (HLA) mismatches, longer cold ischemia 
times, or donor age9. Instead, brain death (BD) itself elicits detrimental effects in the donor. 
BD pathophysiology comprises hemodynamic, hormonal, and inflammatory changes. 
Brain stem herniation results in a catecholamine storm and neurogenic shock through 
ischemia of the spinal cord10. Inflammatory changes are characterized by an increase in 
circulating cytokines such as interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis 
factor-alpha (TNF-α)11-13. These cytokines trigger inflammatory responses in different 
organs through the influx of inflammatory cells. Further, a drop in hormonal levels is 
evident due to pituitary dysfunction14.
BD pathophysiology results in increased systemic and renal lipid peroxidation which 
is measured as malondialdehyde (MDA) levels15-18. Possible causes of the increase in 
lipid peroxidation are the changes in hemodynamics, inflammation, and hormonal 
impairment19-21. Lipid peroxidation leads to membrane dysfunction and cell toxicity22-24. 
BD-associated MDA levels correlate with DGF, acute rejection, and immediate and long-
term renal allograft survival18. Therefore, preventing lipid peroxidation in brain-dead 
donors could lead to improved renal transplantation outcomes.
Ischemia-reperfusion (I-R) injury poses a major threat to transplanted kidneys and 
has serious consequences25. Early I-R injury is characterized by apoptosis and is likely 
mediated by the generation of reactive oxygen species (ROS)26-28. ROS lead to damaged 
cellular components such as DNA, proteins, and lipids29. The ROS-related effects lead 
to the production of pro-inflammatory cytokines and signaling which contributes to 
increased damage and immunogenicity30,31. Consequently, many studies have focused 
on decreasing I-R injury through the administration of anti-oxidative molecules during 
reperfusion. However, these studies have showed differing clinical results.
BD pathophysiology activates donor organs and is associated with worse I-R injury11. 
Considering the correlation between MDA levels and renal function after transplantation, 
we hypothesize that decreasing lipid peroxidation in the brain-dead donor will lead to 
decreased I-R injury and result in improved renal function. In a previous study we showed 
that MnTMPyP, a selective superoxide dismutase mimetic, is effective in reducing  renal 
and systemic MDA levels. Here, we test the effects of MnTMPyP treatment of brain-dead 
rats on kidney function during reperfusion in an isolated perfused kidney (IPK) system.
MATERIALS AND METHODS
Animal BD model
For this experiment, male adult Fisher F344 rats (250-300 g) were used. Animals were 
anesthetized using isoflurane and subsequently intubated. Cannulae were brought into 
the left femoral artery and vein for blood pressure monitoring and administrating plasma 
expanders or norepinephrine. Brain death was induced as described previously. A no. 4 
Fogarty catheter (Edwards Lifesciences Co., Irvine, CA) was placed in the epidural space 
through a frontolateral hole drilled in the skull and slowly inflated (16µl/min) with saline 
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using a syringe pump (Terufusion, Termo Co., Tokyo, Japan). The increase in intracranial 
pressure results in brain death after approximately 30 minutes. Inflation of the balloon 
was stopped when the mean arterial pressure (MAP) reached 80 mmHg due to the 
catecholamine storm characteristic for brain death. Anesthesia was stopped after brain 
dead induction and the animals remained ventilated with O2/air. BD was confirmed by 
the absence of corneal reflexes and an apnoea test. MAP was kept between 80-120 
mmHg by using 10% hydroxyethyl starch (Fresenius Kabi AG, Bad Homburg, Germany), 
and if needed norepinephrine. 4 hours after BD induction blood was collected through 
the abdominal artery after which the organs were flushed with saline. Centrifuged blood 
samples and urine from the bladder were snap frozen. Kidneys were harvested and 
sections stored in formalin as well as snap frozen. Rats were randomly divided, each group 
consisting of eight animals. Sham-operated rats, which were ventilated for half an hour 
under anaesthesia before scarification, served as controls. MnTMPyP (5mg/kg) or saline 
was administered intraperitoneally, 30 min before the start of the operation. MnTMPyP 
was purchased from Merck Millipore (Darmstadt, Germany).
The following experimental groups can be distinguished:
Group 1: Brain dead rats receiving saline vehicle
Group 2: brain dead rats receiving MnTMPyP
Isolated perfused kidney system
To assess renal function after brain death the left kidney was evaluated in an IPK model as 
described before32. The renal artery and ureter are cannulated and placed in a chamber in 
which the kidney is perfused with DMEM supplemented medium. Supplements included 
L-glutamine and pH was adjusted to 7.4. Perfusate and urine samples were collected to 
estimate renal function. Perfusion medium was maintained at 37°C and oxygenated with 
95% O2 and 5% CO2. Kidneys were perfused at a  perfusion pressure of 100 mm HG during 
90 mins. Samples were stored at -80°C.
Determination of superoxide production with dihydroethidium staining
Four μm cryosections were mounted on slides and washed with Dulbecco’s PBS (DPBS). 
Sections were incubated with 10 μM dihydroethidium (Sigma, St. Louis, MO) dissolved 
in DPBS at 37°C in the dark for 30 min. Sections were washed twice with DPBS and 
immediately scanned for superoxide with a Leica inverted fluorescence microscope 
equipped with rhodamine filter settings. Images were acquired at 40X magnification and 
analyzed using NCBI ImageJ.
Determination of lipid peroxidation with thiobarbituric acid reactive substances
MDA was measured as described previously17. MDA is measured fluorescently after 
binding to thiobarbituric acid.  20µL plasma samples were mixed with 2% SDS and 5mM 
butylated hydroxytoluene followed by 400µL 0.1 N HCL, 50µL 10% phosphotungstic acid 
and 200µL 0.7% TBA. The mixture was incubated for 30 min at 97°C. 800µL 1-butanol was 
added to the samples and the centrifuged at 960 g. 200 µL of the 1-butanol supernatant 
was fluorescently measured at 480 nm excitation and 590 nm emission wavelengths.
RNA isolation and qPCR
qPCR experiments were conducted as described before15. Total RNA was isolated from 
rat kidneys using the SV Total RNA isolation kit (Promega, Leiden, the Netherlands) 
according to the manufacturer’s protocol. RNA samples were verified for the absence of 
genomic DNA contamination by performing RT-PCR reactions, in which the addition of 
reverse transcriptase was omitted, using GADPH primers. cDNA synthesis was performed 
from 1 µg total RNA using T11VN oligo’s and M-MLV reverse transcriptase, according 
to suppliers’s protocol (Invitrogen, Breda, The Netherlands). Amplification and detection 
were performed with the ABI Prism 7900-HT Sequence Detection System (Applied 
Biosystems, Foster city) using emission from SYBR green (SYBR green master mix, Applied 
biosystems). All assays were performed in triplicate. After an initial activation step at 50°C 
for 2 min and a hot start at 95°C for 10 min, PCR cycles consisted of 40 cycles of 95°C for 
15 s and 60°C for 60 s. Specificity of qPCR products was routinely assessed by performing 
a dissociation curve at the end of the amplification program and by gel electrophoresis. 
Gene expression was normalized with the mean of ɴ-actin mRNA content and calculated 
relative to controls using the relative standard curve method. Results were finally expressed 
as 2-∆ct (CT threshold cycle). Amplification primers were designed with Primer Express 
software (Applied Biosystems) and validated in a six-step 2-fold dilution series. The primer 
sequences and product sizes are given in table 1.
Table 1. qPCR primer sequences of the genes b-actin and iNOS.







Table 2. Total Noradrenaline (1 mg/ml) and HAES infusion requirements and number of rats which required 
Noradrenaline.
BD + saline BD + MnTMPyP P value
Noradrenaline (ml) 0.31 ± 0.1 0.28 ± 0.3 0.54
HAES (ml) 3.5 ± 0.4 4.1 ± 2.5 0.28
* indicates a significant difference between MnTMPyP- and saline-treated brain-dead rats.
RESULTS
Hemodynamic changes and donor management during BD
BD induction showed the characteristic drop and subsequent increase in blood pressure 
over a mean of 30.5 minutes (Figure 1). All 16 animals (n=8 per group) were kept at a mean 
arterial pressure higher than 80 mmHg during the experiment. No significant differences 
were observed between groups in terms of HAES and NA administration. In saline treated 
brain-dead rats, infusion of 1.5[0.0-4.0] ml HAES 10% was necessary to maintain stable 
blood pressure. In MnTMPyP treated brain-dead rats, infusion of 3.0[2.0-3.5] ml HAES 10% 
was needed to maintain stable blood pressure. Saline treated brain-dead rats required 
0.7[0.0-2.4] mg NA and MnTMPyP treated brain-dead 0.0[0.0-5.1] mg NA.
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Figure 1: Mean arterial pressure (MAP) course during brain-death (BD)- induction and BD. The induction phase 
showed a characteristic drop in blood pressure. No differences were observed in blood pressure levels between 
saline and MnTMPyP-treated brain-dead groups
Renal superoxide production in the brain-dead rat
After 4 hrs, superoxide levels were significantly reduced in brain-dead rats pre-treated 
with MnTMPyP compared to non-treated rats (p < 0.05, Figure 2).
Figure 2: DHE staining for superoxide in brain-dead rats treated with vehicle or MnTMPyP. A, BD + vehicle. B, 
BD + MnTMPyP. MnTMPyP treatment resulted in decreased superoxide production compared to treatment with 
vehicle. * indicates p < 0.05. 40X magnification
Renal lipid peroxidation in the brain-dead rat
MDA levels were significantly reduced after 4 hrs of BD in brain-dead rats pre-treated with 
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Figure 3: Renal levels of lipid peroxidation in brain-dead rats treated with vehicle or MnTMPyP. MnTMPyP 
treatment resulted in decreased renal MDA levels compared to treatment with vehicle. ** indicates p < 0.01 
compared to saline-treated brain-dead rats. 
Renal blood flow and perfusate creatinine levels during reperfusion in the IPK 
model
During reperfusion in the IPK, renal blood flow increased significantly of kidneys from 
brain-dead rats treated with MntMPyP during BD. Renal blood flow was significantly 
increased compared to vehicle treated rats at 30, 60 and 90 minutes of reperfusion (p < 
0.05, Figure 4). Perfusate creatinine levels were significantly reduced during reperfusion of 
kidneys from brain-dead rats treated with MnTMPyP compared to vehicle treatment at 60 
and 90 minutes (p < 0.05).
Figure 4: Assessment of renal flow and creatinine clearance during reperfusion in an isolated perfused kidney 
(IPK) system of kidneys from brain-dead rats pre-treated with vehicle or MnTMPyP. MnTMPyP treatment led to 
increased flow and creatinine clearance compared to non-treated rats. * indicates p < 0.05 between groups.
Renal sodium excretion and urine production during reperfusion in the IPK model
During reperfusion in the IPK, renal sodium excretion decreased significantly of kidneys 
from brain-dead rats treated with MnTMPyP. Renal sodium excretion was decreased 
significantly compared to vehicle treated rats at 60 and 90 minutes of reperfusion (p < 
0.05, Figure 5). Urine output was increased significantly during reperfusion of kidneys 
from brain-dead rats treated with MnTMPyP compared to vehicle treatment at 60 and 90 
minutes (p < 0.05).
Figure 5: Assessment of fractional sodium excretion and urine production during reperfusion in an isolated 
perfused kidney (IPK) system of kidneys from brain-dead rats pre-treated with vehicle or MnTMPyP. MnTMPyP 
pre-treatment led to decreased sodium excretion and increased urine production compared to non-treated rats. * 
indicates p < 0.05 between groups.
Renal weight increase during reperfusion in the IPK model
Renal weight increase was significantly more of kidneys of brain-dead rats treated with 
vehicle compared to MnTMPyP treatment (p < 0.05, Figure 6)
Figure 6: Kidney weight change after reperfusion in an isolated perfused kidney (IPK) model of kidneys from 
brain-dead rats treated with vehicle or MnTMPyP. MnTMPyP treatment led to less weight increase compared to 
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DISCUSSION
The role of antioxidants has been studied extensively in the context of I-R injury33-35. In these 
studies, antioxidants are administered to counteract the detrimental effects of oxidants 
produced during reperfusion. In our study, we counteracted oxidant production in the 
brain-dead donor rat as we hypothesized that oxidative damage in the donor predisposes 
kidneys to worse I-R injury.  Our main findings are that MnTMPyP treatment led to increased 
renal blood flow and function which was assessed during the reintroduction of oxygen in 
an IPK model. This shows that decreasing lipid peroxidation in brain-dead could influence 
rates of DGF, acute rejection, and short and long-term allograft survival since MDA levels 
correlate with these processes18.
In a previous study, we showed that MnTMPyP treatment of brain-dead rats decreases 
renal lipid peroxidation but does not lead to improved renal function in the rat. However, 
in models of sepsis, MnTMPyP treatment leads to improved renal function in the 
animal36,37. The improved renal function in these studies is attributed to the increased 
availability of nitric oxide though the decreased reaction with superoxide. Even though 
renal function decreases during BD, it could be that sepsis elicits more hemodynamic 
instability leading to longer phases of renal ischemia and thereby increased superoxide 
production. Therefore, reducing superoxide levels in sepsis could have an effect on kidney 
function within the rat. The present study shows that decreasing superoxide levels in the 
brain-dead rat leads to improved renal function after the kidneys have been subjected 
to I-R injury. We believe that the decrease in superoxide levels and thereby the decreased 
lipid peroxidation in the brain-dead rat results in less susceptibility to I-R injury. This idea 
has been shown before in the sense that BD primes organs to worse I-R injury11. This 
could lead to decreased sodium pump dysfunction and apoptosis of proximal tubular 
cells which could explain the increased sodium reabsorption, increased urine output, and 
decreased perfusate creatinine levels we observed. The decreased creatinine levels in 
the perfusate could also be influenced by the increased renal blood flow we observed. 
This increase in renal blood flow could be related to effects of manganese which forms 
the core of MnTMPyP. Manganese increases renal blood flow and GFR by acting as a 
calcium entry blocker38. Another explanation for the increased renal blood flow could be 
the effect of superoxide scavenging on renal resistance. Superoxide oxidizes membrane 
lipids which causes loss of membrane barriers39. Furthermore, mitochondrial membranes 
are affected which results in less ATP production for Na+/K+ pumps and leads to cellular 
swelling causing obstruction of the microvasculature and tubules. 
Using the IPK model, we tested renal function during the reintroduction of oxygen.  In this 
manner, I-R injury is mimicked in the sense that organs experienced a period of ischemia 
during organ harvest and the subsequent cold flush after which they were subjected to 
the reintroduction of oxygen. However, this model does not resemble all aspects of clinical 
I-R injury as it does not incorporate certain elements such as the presence of leukocytes 
in the perfusion medium. Future research should study longer term effects of MnTMPyP 
treatment on I-R injury. Nevertheless, our aim was to test the early effects of MnTMPyP 
treatment on kidney function with minimal external influences. Therefore, our research 
question could be addressed appropriately with the use of this model.
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